Page 2 - Principal Securities Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Principal securities inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Principal Securities Inc Today - Breaking & Trending Today

Franklin U.S. Mid Cap Multifactor Index ETF (BATS:FLQM) Hits New 1-Year High at $51.43

Franklin U.S. Mid Cap Multifactor Index ETF (BATS:FLQM – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $51.43 and last traded at $51.44, with a volume of 60772 shares trading hands. The stock had previously closed at $51.26. Franklin U.S. Mid […] ....

Wealth Management Corp , Franklin Templeton , Redhawk Wealth Advisors Inc , Principal Securities Inc , Company Profile , Cap Multifactor Index , Get Free Report , Private Capital , Wealth Advisors , Private Trust , Cap Equity ,

Insider Selling: Okta, Inc. (NASDAQ:OKTA) Director Sells $1,645,972.82 in Stock

Okta, Inc. (NASDAQ:OKTA – Get Free Report) Director Jacques Frederic Kerrest sold 18,878 shares of the firm’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $87.19, for a total transaction of $1,645,972.82. The transaction was disclosed in a filing with the SEC, which can be accessed […] ....

United States , Robertw Baird , Sanfordc Bernstein , Jacques Frederic Kerrest , Venturi Wealth Management , Okta Inc , Okta Company Profile , City State Bank , Principal Securities Inc , Eversource Wealth Advisors , Jpmorgan Chase Co , Get Free Report , Director Jacques Frederic Kerrest , State Bank , Source Wealth Advisors , Wealth Management , Principal Securities , Single Sign On , Adaptive Multi Factor Authentication , Access Gateway , Workforce Identity Cloud , Okta Device Access , Okta Daily ,

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Director Matthew L. Posard Sells 10,000 Shares

Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) Director Matthew L. Posard sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $50.01, for a total value of $500,100.00. Following the completion of the transaction, the director now directly owns 109,755 shares […] ....

United States , Matthewl Posard , Piper Sandler , Principal Securities Inc , Securities Exchange Commission , Wells Fargo Company , Rise Advisors , Halozyme Therapeutics Inc , First Horizon Advisors Inc , Halozyme Therapeutics Company Profile , Fidelis Capital Partners , Whittier Trust Co , Halozyme Therapeutics , Get Free Report , Director Matthew , Exchange Commission , Capital Partners , First Horizon Advisors , Horizon Advisors , Halozyme Therapeutics Daily ,